Sreoshi Chatterjee 452 posts 0 comments

Vanda Pharmaceuticals asserted that HETLIOZ which is a circadian regulator exhibited significant and clinically meaningful benefits in symptoms of jet lag disorder. Jet lag disorder…
Read More...

MyBiotics Pharma which is a microbiome therapeutics company announced that it has entered into second option agreement with Ferring Holding Ltd. for the validation of MyBiotics'…
Read More...

Benitec Biopharma which is a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its patented gene-silencing technology named ddRNAi…
Read More...

Trovagene which is a precision medicine biotechnology company developing targeted cancer therapeutics asserted that the initial patient successfully completed first cycle 1 Treatment in…
Read More...

In a bid to enhance and streamline data management processes for Aequus- sponsored clinical trials studying specific Cannabinoid-rich formulations for treating a number of neurological…
Read More...

Lyric Pharmaceuticals which is a biopharmaceutical company asserted the completion of enlisting for PROMOTE Study which is an international multi-center, randomized, controlled Phase 2…
Read More...

Global pharmaceutical company, Glenmark affirmed poster presentations of data from clinical studies of Ryaltris which is an investigational fixed-dose combination nasal spray for…
Read More...

MicuRx Pharmaceuticals asserted that the global partnership Combating Antibiotic Resistant Bacteria Accelerator has dedicated up to $5.2 million of non-dilutive financing for IND…
Read More...

Aimmune Therapeutics which is a bio pharmaceutical company curating treatments for fatal food allergies, announced that the results of its pivotal Phase 3 PALISADE trial of AR101 for…
Read More...

London and New York based gene therapy company, MeiraGTx declared that the European Medicines Agency has extended Priority Medicines (PRIME) designation to MeiraGTx’s gene therapy…
Read More...